Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K250354

Viz Subdural+, Viz SUBDURAL PLUS

Viz.ai, Inc.

Authorized purpose: Viz Subdural+ labels, visualizes, and quantifies subdural collections from single-time-point non-contrast head CT, reporting collection grayscale value, total volume, widest width, and midline shift as annotated DICOM images for physician review with original CT.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-06-10
FDA-cleared K232363

Viz HDS, Viz Volume Plus, Viz ICH+

Viz.ai, Inc.

Authorized purpose: Automatically label, visualize, and quantify segmentable brain structures on single-time-point non-contrast head CT, including intracranial hyperdensities, lateral ventricles, and midline shift; output must be reviewed with the original images by a physician.

Modality
CT/CTA
Anatomy
Brain (intracranial hyperdensities, lateral ventricles, and midline shift)
Decision
2024-02-05
FDA-cleared K223443

Viz AAA

Viz. ai, Inc.

Authorized purpose: Provides computer-assisted triage and notification for CTA abdomen studies with suspected abdominal aortic aneurysms.

Modality
CT/CTA
Anatomy
Abdomen/abdominal aorta
Decision
2023-03-17
FDA-cleared K223042

Viz LVO ContaCT

Viz.ai, Inc.

Authorized purpose: Notification-only parallel workflow to identify and communicate suspected large vessel occlusion on acute brain CTA to a neurovascular specialist; identification is not for diagnosis beyond notification.

Modality
CT/CTA
Anatomy
Brain, specifically the terminal internal carotid artery and MCA-M1 vessels
Decision
2022-10-21
FDA-cleared K221100

Viz RV/LV

Viz.ai, Inc.

Authorized purpose: Measures maximal right- and left-ventricular diameters from volumetric CTPA and reports their ratio.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2022-08-29
FDA-cleared K220439

Viz SDH

Viz.ai, Inc.

Authorized purpose: Notification-only parallel workflow for identifying and communicating images of patients with suspected subdural hemorrhage from non-contrast head CT to neurovascular or neurosurgical specialists; not diagnostic beyond notification.

Modality
CT/CTA
Anatomy
Brain
Decision
2022-07-25
FDA-cleared K213319

Viz ANEURYSM, Viz ANX

Viz.ai, Inc.

Authorized purpose: Triage and notification of suspected head aneurysms during routine care; not a diagnostic device.

Modality
CT/CTA
Anatomy
Head
Decision
2022-02-18
FDA-cleared K210209

Viz ICH

Viz.ai, Inc.

Authorized purpose: Notification-only, parallel workflow tool for hospital networks and trained clinicians that analyzes acute non-contrast brain CT and communicates suspected intracranial hemorrhage to a neurovascular or neurosurgical specialist for review.

Modality
CT/CTA
Anatomy
Head/brain; suspected intracranial hemorrhage.
Decision
2021-03-23
FDA-cleared K193658

Viz ICH

Viz.ai, Inc.

Authorized purpose: Notification-only triage of adult noncontrast head CT for suspected intracranial hemorrhage, with specialist notification; results do not replace diagnostic interpretation.

Modality
CT/CTA
Anatomy
Brain
Decision
2020-03-18
FDA-cleared K180161

Viz CTP

Viz.ai, Inc.

Authorized purpose: Image processing, analysis, and communication of dynamic brain CT perfusion datasets to calculate perfusion parameters for review by trained professionals.

Modality
CT/CTA
Anatomy
Brain
Decision
2018-04-20